Recent
Is More Frequent Surveillance Associated With Better Survival for Patients With NSCLC?
FDA Approves Atezolizumab Combination in First-Line Treatment of Metastatic Nonsqumous NSCLC
Radiation-Based Trimodality Therapy in Stage III NSCLC
Combined Immunotherapy Treatment Studied in Advanced Lung Cancer
Ongoing
Immune Checkpoint Inhibitors in Lung Cancer: No Longer the Road Less Traveled?
The Evolving Landscape of Immunotherapy and Targeted Therapy for Non–Small Cell Lung Cancer
Selecting Cancer Treatment: The Role of Tumor Molecular Profiling and Liquid Biopsy
Stage III NSCLC: Practical Application of Immune Checkpoint Inhibition After Chemoradiotherapy
